ATE434604T1 - Amorphes tamsulosin-hydrochlorid - Google Patents

Amorphes tamsulosin-hydrochlorid

Info

Publication number
ATE434604T1
ATE434604T1 AT05715224T AT05715224T ATE434604T1 AT E434604 T1 ATE434604 T1 AT E434604T1 AT 05715224 T AT05715224 T AT 05715224T AT 05715224 T AT05715224 T AT 05715224T AT E434604 T1 ATE434604 T1 AT E434604T1
Authority
AT
Austria
Prior art keywords
amorphic
hydrochloride
tamsulosine
tamsulosine hydrochloride
lyophilization
Prior art date
Application number
AT05715224T
Other languages
English (en)
Inventor
Zoran Ham
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE434604T1 publication Critical patent/ATE434604T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT05715224T 2004-01-29 2005-01-28 Amorphes tamsulosin-hydrochlorid ATE434604T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200400032A SI21702A (en) 2004-01-29 2004-01-29 Preparation of amorphous form of tamsulosin
PCT/EP2005/000875 WO2005075416A1 (en) 2004-01-29 2005-01-28 Amorphous tamsulosin hydrochloride

Publications (1)

Publication Number Publication Date
ATE434604T1 true ATE434604T1 (de) 2009-07-15

Family

ID=34836935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05715224T ATE434604T1 (de) 2004-01-29 2005-01-28 Amorphes tamsulosin-hydrochlorid

Country Status (6)

Country Link
US (1) US20070161709A1 (de)
EP (1) EP1713769B1 (de)
AT (1) ATE434604T1 (de)
DE (1) DE602005015083D1 (de)
SI (2) SI21702A (de)
WO (1) WO2005075416A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066565B2 (ja) * 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6835853B2 (en) * 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
PT1443917E (pt) * 2001-11-07 2006-06-30 Synthon Bv Comprimidos de tamsulosina

Also Published As

Publication number Publication date
DE602005015083D1 (de) 2009-08-06
WO2005075416A1 (en) 2005-08-18
SI1713769T1 (sl) 2009-10-31
EP1713769B1 (de) 2009-06-24
SI21702A (en) 2005-08-31
EP1713769A1 (de) 2006-10-25
US20070161709A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
LTPA2018010I1 (lt) Žmogaus anti-IL-23 antikūnai, kompozicijos, metodai ir panaudojimai
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
UY29183A1 (es) Formulaciones
EA200702643A1 (ru) Антитела, связывающие tweak
TW200732349A (en) Anti-OX40L antibodies and methods using same
EA200701918A1 (ru) Белок липокалин
EP1912667A4 (de) Konzentrierte proteinlyophilisate, verfahren und anwendungen
IL186965A0 (en) Anti-il-6 antibodies, compositions, methods and uses
EP1963500A4 (de) Zusammensetzungen mit ausgerichteten und immobilisierten makromolekülen sowie verfahren zu ihrer herstellung
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
NO20092611L (no) Krystallinsk faststoff Rasagilin base
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
WO2007021672A3 (en) Vaccination against dengue virus infection
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
WO2007120334A8 (en) Methods and compositions for targeting polyubiquitin
NO20081364L (no) Amorfe faste dispersjoner
EP1945257A4 (de) Antikörperzusammensetzungen, verfahren zur behandlung von neoplastischer erkrankung und verfahren zur regulierung der fertilität
DE602005003246D1 (de) Polyalkyleniminderivat, dessen Herstellungsverfahren und Verwendungen
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2006100430A3 (en) Polypeptides
DE602006010187D1 (de) Einzelsequenzhybridisierungssonden
FI20055133A (fi) Iskulaite

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties